Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|December 4, 2004
Diagnostic usefulness of bronchoalveolar lavage in Hermansky-Pudlak syndrome: a case with double lung cancersKumi Takahashi, Takashi Ishida, Go Ogura, et al.
Modern Rheumatology|February 21, 2019
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trialsMasayoshi Harigai, Tsutomu Takeuchi, Josef S Smolen, et al.
Modern Rheumatology|August 6, 2022
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillanceMichiaki Takagi, Tatsuya Atsumi, Hiroaki Matsuno, et al.
BMC Research Notes|June 6, 2015
A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancerHiroyuki Minemura, Hiroshi Yokouchi, Keisuke Azuma, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 10, 2009
[Transesophageal endoscopic ultrasonography guided-fine needle aspiration for the diagnosis of sarcoidosis]Kazue Saito, Yoshinori Tanino, Yayoi Inokoshi, et al.
Modern Rheumatology|January 18, 2011
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumabSumiyuki Nishida, Tomio Kawasaki, Hirokazu Kashiwagi, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|June 14, 2006
Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patientsTaeko Ishii, Hiroaki Onda, Akie Tanigawa, et al.
The Journal of Rheumatology|September 17, 2018
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in TreatmentJosef S Smolen, Mark C Genovese, Tsutomu Takeuchi, et al.
Modern Rheumatology|August 9, 2024
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance studyNami Okamoto, Tatsuya Atsumi, Michiaki Takagi, et al.
The Journal of Biological Chemistry|July 12, 2014
Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell lineSakae Maeda, Hiroshi Wada, Yoko Naito, et al.
Pageof 5